Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 70.4% to close at $18.78 after the company on Friday announced a $6 million private placement priced at $8.68 per share.
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares surged 65% to close at $38.11 on Monday after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
PolyPid Ltd. (NASDAQ: PYPD) gained 58.3% to close at $1.71. The company earlier announced it will present Phase 2 D-PLEX₁₀₀ data at the European Society for Coloproctology Scientific Conference next week.
Arqit Quantum Inc. (NASDAQ: ARQQ) shares gained 38.1% to close at $7.72. The company will present at the H.C. Wainwright 24th Annual Global Investment Conference later today.
PaxMedica, Inc. (NASDAQ: PXMD) rose 36.6% to settle at $4.33 after TardiMed Sciences' Michael Derby on Friday disclosed a 63.4% active stake in the company.
Allego N.V. (NYSE: ALLG) jumped 33.5% to close at $5.90.
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) jumped 30.7% to close at $12.09. IDEAYA Biosciences disclosed interim Phase 2 clinical results for darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma.
Clovis Oncology, Inc. (NASDAQ: CLVS) climbed 30.4% to close at $1.50 after the company said Rubraca (Rucaparib) as first-line maintenance treatment improves progression-free survival in women with advanced ovarian cancer across disease risk subgroups.
Annovis Bio, Inc. (NYSE: ANVS) gained 29.5% to settle at $19.82 on above-average volume.
Kaspien Holdings Inc. (NASDAQ: KSPN) surged 27.7% to close at $2.86.
IHS Holding Limited (NYSE: IHS) jumped 24.9% to close at $7.83. IHS Holding, last month, said Q2 EPS results down year-over-year.
Gogoro Inc. (NASDAQ: GGR) gained 21.3% to close at $5.25. Gogoro recently launched its battery-swapping system and Smart scooters in the Tel Aviv metropolitan area.
ImmunityBio, Inc. (NASDAQ: IBRX) jumped 20.9% to close at $5.61.
POINT Biopharma Global Inc. (NASDAQ: PNT) rose 19.8% to close at $10.27 after the company published a poster at ESMO Congress 2022 highlighting updated safety and efficacy data from its Phase 3 SPLASH trial of PNT2002 in metastatic castration-resistant prostate cancer.
Rackspace Technology, Inc. (NASDAQ: RXT) gained 18.8% to settle at $6.32.
Magic Empire Global Limited (NASDAQ: MEGL) jumped 17.9% to close at $6.00.
Regulus Therapeutics Inc. (NASDAQ: RGLS) rose 16.9% to close at $1.94 after the company announced topline safety and PK data from its Phase 1 SAD clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and PK profile.
TuanChe Limited (NASDAQ: TC) gained 16.8% to close at $3.20.
Asana, Inc. (NYSE: ASAN) climbed 16.4% to close ...
Benzinga
